Atom Investors LP Merck & Co., Inc. Transaction History

Atom Investors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $738,962 - $793,638	-5,969 Reduced 43.29%	7,820 $968,000
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $1.56 Million - $1.82 Million	13,789 New	13,789 $1.82 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $211,491 - $264,920	-2,926 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $209,735 - $230,656	2,926 New	2,926 $220,000
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $523,490 - $580,967	-7,294 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $533,774 - $605,037	7,294 New	7,294 $605,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $257B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.